Startup companies
fromFast Company
1 day agoNovo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers
Novo Nordisk's market outlook improves with FDA's ban on GLP-1 drug copycats.
Despite profit forecasts lowering, investor sentiment towards Novo Nordisk remains optimistic.